Potential of Immuno–Positron Emission Tomography for Tumor Imaging and Immunotherapy Planning

This publication has 7 references indexed in Scilit:

• Performance of Immuno–Positron Emission Tomography with Zirconium-89-Labeled Chimeric Monoclonal Antibody U36 in the Detection of Lymph Node Metastases in Head and Neck Cancer Patients
  Clinical Cancer Research, 2006
• Fluorinated tracers for imaging cancer with positron emission tomography
  European Journal of Nuclear Medicine and Molecular Imaging, 2004
• Improving the evaluation of new cancer treatments: challenges and opportunities
  Nature Reviews Cancer, 2003
• Molecular Imaging and Biological Evaluation of HuMV833 Anti-VEGF Antibody: Implications for Trial Design of Antiangiogenic Antibodies
  JNCI Journal of the National Cancer Institute, 2002
• PET quantitation and imaging of the non-pure positron-emitting iodine isotope 124I
  Applied Radiation and Isotopes, 2002
• Quantitative studies of monoclonal antibody targeting to disialoganglioside GD2 in human brain tumors
  European Journal of Nuclear Medicine and Molecular Imaging, 1995
• Evaluation of desferal as a bifunctional chelating agent for labeling antibodies with Zr-89
  International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1992